Investor Relations contacts
Home / Investor Relations / Investor Relations contacts
Contact Investor Relations
Andy Barnett
Head of Investor Relations
Christer Gruvris
Executive Director of Investor Relations
BioPharmaceuticals (Cardiovascular, Renal and Metabolism), Finance & Fixed Income
Lauren Swales
Director of Investor Relations
Rare Disease
Isabel Gibson
Director of Investor Relations
Oncology
Elizabeth Walton
Director of Investor Relations
BioPharmaceuticals (Respiratory & Immunology) and Sustainability
Philip Sparks
Director of Investor Relations
BioPharmaceuticals (Vaccines & Immune Therapies)
Rachel Korolyshun
Senior Manager, Investor Relations
Rare Disease and Sustainability
Contact us on:
Shareholder Registrar Information
Ordinary Shares (Equiniti)
ADR Holders (EQ Shareowner Services)
Stockholm Nasdaq Shares (Euroclear)
TR1 notifications
-
Shareholder information
Please find relevant shareholder information and shareholder tools on this page
-
Shareholder FAQs
Answers to frequently asked shareholder questions
-
Governance
We apply the principles of good corporate governance in the UK Corporate Governance Code and related guidance
